sobuzoxane and Lymphoma studies

sobuzoxane and Lymphoma

sobuzoxane has been researched along with Lymphoma in 3 studies

sobuzoxane: used in treatment of leukemia L1210

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research Excerpts

Excerpt	Relevance	Reference
" The patient achieved a complete response (CR) after treatment with oral low-dose sobuzoxane and etoposide combined with rituximab."	5.40	[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma]. ( Abe, Y; Choi, I; Haji, S; Kiyasu, J; Ohshima, K; Suehiro, Y; Toyoda, K; Tsuda, M; Uike, N, 2014)
"Sobuzoxane (MST-16) is an analogue of ICRF-159 which was once evaluated on the clinical efficacies in England."	2.39	[A novel antitumor agent, sobuzoxane (MST-16)]. ( Tsukagoshi, S, 1994)
" The patient achieved a complete response (CR) after treatment with oral low-dose sobuzoxane and etoposide combined with rituximab."	1.40	[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma]. ( Abe, Y; Choi, I; Haji, S; Kiyasu, J; Ohshima, K; Suehiro, Y; Toyoda, K; Tsuda, M; Uike, N, 2014)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (33.33)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (33.33)

24.3611

2020's

1 (33.33)

2.80

Authors

Authors	Studies
Ohmoto, A	1
Fuji, S	1
Toyoda, K	1
Abe, Y	1
Tsuda, M	1
Haji, S	1
Choi, I	1
Suehiro, Y	1
Kiyasu, J	1
Ohshima, K	1
Uike, N	1
Tsukagoshi, S	1

Studies

Ohmoto, A

Fuji, S

Toyoda, K

Abe, Y

Tsuda, M

Haji, S

Choi, I

Suehiro, Y

Kiyasu, J

Ohshima, K

Uike, N

Tsukagoshi, S

Reviews

1 review available for sobuzoxane and Lymphoma

Article	Year
[A novel antitumor agent, sobuzoxane (MST-16)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7 Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Humans; Leukemia, Experimental;	1994

Article

Year

[A novel antitumor agent, sobuzoxane (MST-16)].

Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Humans; Leukemia, Experimental;

1994

Other Studies

2 other studies available for sobuzoxane and Lymphoma

Article	Year
Clinical feasibility of oral low-dose etoposide and sobuzoxane for conventional chemotherapy-intolerant lymphoma patients. Expert review of anticancer therapy, 2021, Volume: 21, Issue:7 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Feasibility Studies	2021
[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Herpesvirus 8, Human; Humans; Lymph	2014

Article

Year

Clinical feasibility of oral low-dose etoposide and sobuzoxane for conventional chemotherapy-intolerant lymphoma patients.

Expert review of anticancer therapy, 2021, Volume: 21, Issue:7

Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Feasibility Studies

2021

[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:7

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Herpesvirus 8, Human; Humans; Lymph

2014